Interactions between trimpex(trimethoprim) and Dilantin 125 (phenytoin)
trimethoprim and phenytoin (Moderate Drug-Drug)
MANAGEMENT: Monitoring for clinical and laboratory evidence of hydantoin toxicity is recommended. Dose adjustments may be necessary. Patients should be advised to notify their physician if they experience symptoms of hydantoin toxicity (e.g., drowsiness, visual disturbances, change in mental status, seizures, nausea, or ataxia).






